+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antihypertensive Drugs Market 2022-2026 - Product Thumbnail Image

Antihypertensive Drugs Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Myeloproliferative Disorders Drugs Market Report 2025 - Product Thumbnail Image

Myeloproliferative Disorders Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bone Cancer Treatment Market Report 2025 - Product Thumbnail Image

Bone Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Dyslipidemia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dyslipidemia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
Akt1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Akt1 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
BET Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

BET Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
Loading Indicator